⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLRBZ News
Cellectar Biosciences Announces Subset of CLOVER WaM Clinical Trial Data Accepted for Presentation at the American Society of Clinical Oncology Conference 2026
globenewswire.com
CLRBW
CLRB
CLRBZ
Cellectar Enrolls First Patient in CLR 125 Auger-Emitting Radioconjugate Phase 1b Clinical Trial Targeting Refractory Triple Negative Breast Cancer (TNBC)
globenewswire.com
CLRBW
CLRB
CLRBZ
Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates
globenewswire.com
CLRBW
CLRB
CLRBZ
Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026
globenewswire.com
CLRBW
CLRB
CLRBZ
Cellectar Biosciences Expands Global Intellectual Property Estate
globenewswire.com
CLRBW
CLRB
CLRBZ